mRNA |
Bortezomib |
gCSI |
pan-cancer |
AAC |
0.07 |
0.2 |
mRNA |
Roscovitine |
FIMM |
pan-cancer |
AAC |
0.19 |
0.2 |
mRNA |
KIN001-236 |
GDSC1000 |
pan-cancer |
AAC |
-0.039 |
0.3 |
mRNA |
KIN001-135 |
GDSC1000 |
pan-cancer |
AAC |
-0.063 |
0.3 |
mRNA |
Tamoxifen |
CTRPv2 |
pan-cancer |
AAC |
-0.044 |
0.3 |
mRNA |
erlotinib:PLX-4032 (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.044 |
0.3 |
mRNA |
Nutlin-3 |
CTRPv2 |
pan-cancer |
AAC |
-0.04 |
0.3 |
mRNA |
pifithrin-mu |
CTRPv2 |
pan-cancer |
AAC |
-0.04 |
0.3 |
mRNA |
selumetinib:BRD-A02303741 (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.04 |
0.3 |
mRNA |
BRD-K99006945 |
CTRPv2 |
pan-cancer |
AAC |
0.06 |
0.3 |